WU Wei-kang
Impact in
- Ophthalmology top 5%
- Retinal Diseases and Treatments
- Geriatrics and Gerontology top 10%
- Sirtuins and Resveratrol in Medicine
Papers in
-
- Traditional Chinese Medicine Studies 5
-
- Neuroinflammation and Neurodegeneration Mechanisms 5
- Co-authors
- Andrew D. DickLindsay B. NicholsonLihe LuDavid O. BatesHuimin YuYanling ChenXiaohong LiJianyun Yan
- Journals
- Chinese Journal of Integrative Medicine (6 papers)PLoS ONE (2 papers)Scientific Reports (1 paper)International Journal of Cardiology (1 paper)Lipids in Health and Disease (1 paper)
- Partner nations
- ChinaUnited KingdomMacao
In The Last Decade
WU Wei-kang
37 papers receiving 844 citations
Peers
Comparison fields: 5 of 84
- Ophthalmology 130
- Geriatrics and Gerontology 49
- Neurology 93
- Physiology 46
- Pharmacology 60
Countries citing papers authored by WU Wei-kang
This map shows the geographic impact of WU Wei-kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by WU Wei-kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites WU Wei-kang more than expected).
Fields of papers citing papers by WU Wei-kang
This network shows the impact of papers produced by WU Wei-kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by WU Wei-kang. The network helps show where WU Wei-kang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside WU Wei-kang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 1 | |
| 2 | 2018 | 6 | |
| 3 | 2017 | 10 | |
| 4 | 2016 | 11 | |
| 5 | 2015 | 32 | |
| 6 | CD200 Receptor signaling subverts pro-angiogenic macrophage phenotype generation and experimental chorioretinal neovascularisation | 2013 | 1 |
| 7 | 2013 | 30 | |
| 8 | 2013 | 76 | |
| 9 | 2013 | 98 | |
| 10 | 2013 | 60 | |
| 11 | Resveratrol reverses D-galactose-induced senescence in cardiomyocytes | 2012 | 1 |
| 12 | 2012 | 11 | |
| 13 | Research into hypocholesterolemic effects and the mechanisms of FPS in dietary hypercholestrolemic rats | 2011 | 2 |
| 14 | Effects of Aconiti tuber polysaccharides on hypercholesterolemia and hepatic cholesterol 7α-hydroxylase expression in rats | 2011 | 1 |
| 15 | 2011 | 13 | |
| 16 | 2010 | 41 | |
| 17 | 2010 | 142 | |
| 18 | 2008 | 148 | |
| 19 | 2006 | 6 | |
| 20 | 2000 | 2 |
About WU Wei-kang
WU Wei-kang is a scholar working on Complementary and alternative medicine, Neurology, Geriatrics and Gerontology, Developmental Neuroscience and Complementary and Manual Therapy, having authored 37 papers that have together received 860 indexed citations. Recurring topics across this work include Neuroinflammation and Neurodegeneration Mechanisms (5 papers), Traditional Chinese Medicine Studies (5 papers), Nitric Oxide and Endothelin Effects (3 papers), Hepatitis B Virus Studies (3 papers), Autophagy in Disease and Therapy (3 papers), Immune cells in cancer (3 papers), Hepatitis C virus research (3 papers) and Anesthesia and Neurotoxicity Research (2 papers). The work is most often cited by research in Ophthalmology (130 citations), Geriatrics and Gerontology (49 citations), Neurology (93 citations), Physiology (46 citations) and Pharmacology (60 citations). WU Wei-kang has collaborated with scholars based in China, United Kingdom and Macao. Frequent co-authors include Andrew D. Dick, Lindsay B. Nicholson, Lihe Lu, David O. Bates, Huimin Yu, Yanling Chen, Xiaohong Li, Jianyun Yan, Xi‐Yong Yu and Qin Zhou. Their work appears in journals such as Chinese Journal of Integrative Medicine, PLoS ONE, Scientific Reports, International Journal of Cardiology and Lipids in Health and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.